A MULTI-CENTER, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EVALUATE SHORT-TERM SAFETY AND EFFICACY AND LONG-TERM MAINTENANCE OF TWO DOSE LEVELS OF RABEPRAZOLE SODIUM DELAYED-RELEASE PEDIATRIC BEAD FORMULATION IN 1 TO 11 YEAR-OLD PEDIATRIC SUBJECTS WITH ENDOS

(1) JOHNSON & JOHNSON

(2) Pediatric & Adolescent Gastroenterology & Nutrition

(3) The Children’s Memorial Health Institute



This item was part of the Oesophageal, Gastric and Duodenal Disorders III session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A369